Nanoparticles Learning Objective

0.0(0)
Studied by 8 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/28

encourage image

There's no tags or description

Looks like no tags are added yet.

29 Terms

1
New cards
  1. In general, can nanoparticles permeate cell membranes better than a small lipophilic molecule in solution?


No.

2
New cards
  1. Do glucose and small ions like calcium require transporter proteins to cross the plasma membrane?

Yes.

3
New cards
  1. Is it generally difficult for a hydrophilic molecule (even <500 Da) to cross the plasma membrane without transporter proteins?

Yes.

4
New cards
  1. Which types of drugs benefit most from nanoparticle-enhanced membrane transport? (a) well permeable small molecules (b) molecules degraded by extracellular or cellular components (c) poorly permeable molecules

B and C.

5
New cards
  1. What properties of antibodies allow long circulation / low clearance by the kidneys and liver?

Size above the glomerular filtration cutoff of ~4 nm, and a hydrophilic surface.

6
New cards
  1. What properties of viruses allow them to infect remote parts of the body?

Cell surface proteins/features that allow cell entry, and dose amplification due to replication in the host.

7
New cards
  1. What properties of bacteria allow them to cross barriers and infect remote parts of the body?

Endotoxins released can alter barriers and increase permeability; bacterial dose amplifies in the host due to replication.

8
New cards
  1. What does enhanced permeation and retention (EPR) imply in cancer drug delivery with nanoparticles?

Higher permeability across leaky tumor vasculature relative to normal (tight) vasculature, and reduced removal from the tumor site due to lower lymphatic clearance.

9
New cards
  1. Does cellular uptake increase or decrease with increasing particle size?

Decreases (ARPE-19 uptake was highest for 20 nm particles and lowest for 1000-2000 nm).

10
New cards
  1. Is drug release more prolonged with nanoparticles or microparticles?

Microparticles: lower surface/volume ratio and less surface area exposed to biological fluids.

11
New cards
  1. For intracellular gene delivery, which is more suitable: nanoparticle or microparticle?

Nanoparticle, since cell entry is low for the hydrophilic macromolecules used in gene therapy.

12
New cards
  1. Do mRNA vaccines for SARS-CoV-2 use nanoparticles or microparticles?

Nanoparticles (lipid nanoparticles; Comirnaty and Spikevax).

13
New cards
  1. Which settle more rapidly when resuspended: nanoparticles or microparticles?

Microparticles. Settling velocity rises steeply with size (100 nm = 4.3 nm/s; 1,000 nm = 430 nm/s; 10,000 nm = 43,005 nm/s). A 100 nm particle takes ~2.69 days to settle 1 mm, so nanoparticles stay suspended.

14
New cards
  1. Which particles may collide more times with a cell surface receptor: nanoparticles or microparticles?

Nanoparticles, due to more Brownian (random) movement.

15
New cards
  1. For a well permeable corticosteroid intended for 6-month treatment in the eye, which is more suitable: nanoparticle or microparticle?

Microparticle (more prolonged release; the drug is well permeable so it does not need nanoparticle-enhanced entry).

16
New cards
  1. Benefits of paclitaxel-albumin nanoparticles (Abraxane) vs paclitaxel in Cremophor EL (Taxol)?

No solvent toxicity (no need for corticosteroid and antihistamine premedication); 30 min vs 3 hr infusion; 1.5x dose tolerated; 2x better response rate. Abraxane = paclitaxel bound to albumin (130 nm), approved January 2005.

17
New cards
  1. Which materials are generally used in preparing nanoparticles?

Pure drug particles; composite particles of drug + carrier (lipids, proteins, polymers, etc.); particle size stabilizers may be included.

18
New cards
  1. Do sticky, rapid uptake nanoparticles likely increase ocular delivery of a poorly permeable drug?

Yes. Eye drops have short residence time, so sticky particles adhere better to the ocular surface, and rapid entry limits removal by blinking. Nanoparticles also enhance cell uptake of poorly permeable drugs.

19
New cards

BONUS: Nanoparticle settling velocity vs size

1 nm = 0.00043 nm/s; 10 nm = 0.043; 100 nm = 4.30; 1,000 nm = 430; 10,000 nm = 43,005. A 100 nm particle takes 2.69 days to settle 1 mm (superior ability to remain suspended).

20
New cards

BONUS: Brownian displacement in 1 second vs size

1 nm = 54,250 nm; 10 nm = 17,155; 100 nm = 5,425; 1,000 nm = 1,716; 10,000 nm = 543. Nanoparticles are highly mobile, so interactions with cells are highly likely.

21
New cards

BONUS: Percent surface molecules vs particle size (1 nm low MW drug)

1 nm = 100%; 10 nm = 27.1%; 100 nm = 2.97%; 1,000 nm = 0.30%; 10,000 nm = 0.03%. Smaller particles have more surface exposure, so faster release.

22
New cards

BONUS: Benefits of nanotechnology for drug and gene delivery

Enhanced permeation and retention; enhanced cell uptake (poorly permeable drugs); targeting to cells and organelles; prolonged suspension; stimuli-sensitive drug release; sustained delivery is feasible, but larger systems might provide more prolonged release.

23
New cards

BONUS: Selection criteria for a nano delivery system

Disease, drug, route, NP disposition, safety, and IP. All nanosystems (albumin, chitosan, PAMAM dendrimer, PLGA, PEG-coated liposome) can be functionalized.

24
New cards

BONUS: Recently approved nanomedicines

Onpattro (patisiran, siRNA in lipid NP; hATTR polyneuropathy; 2018). Comirnaty (mRNA for SARS-CoV-2 spike in lipid NP; COVID-19 prevention; 2021). Spikevax (same type; 2022).

25
New cards

BONUS: Sticky/rapid uptake NP in the eye

Used in eye drops. Short residence time of drops means sticky particles adhere better to the ocular surface; rapid entry limits removal by blinking.

26
New cards

BONUS: Stealth/targeting NP for IV dosing in retinal vascular leakage

Small NP reach the retina via leaky vascular regions. Stealth is imparted by coating with inert polymers like PEG, which diminishes uptake by circulating cells.

27
New cards

BONUS: Stealth/slow release/diffusible NP in the vitreous

Stealth minimizes clearance from the eye; slow release limits frequent intravitreal injections (avoids endophthalmitis); diffusible NP are needed to reach retinal tissue beyond the vitreous.

28
New cards

BONUS: Shock/sono/photo responsive NP for the eye

NPs made of materials responsive to electrical input, ultrasound, or light, so these stimuli can control drug release at the target site.

29
New cards